Larson Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1K | Sell |
310
-1
| -0.3% | -$49 | ﹤0.01% | 1613 |
|
|
2025
Q1 | $10.6K | Sell |
311
-159
| -34% | -$5.41K | ﹤0.01% | 1604 |
|
|
2024
Q4 | $18.5K | Sell |
470
-14
| -3% | -$551 | ﹤0.01% | 1244 |
|
|
2024
Q3 | $22.7K | Sell |
484
-81
| -14% | -$3.81K | ﹤0.01% | 1143 |
|
|
2024
Q2 | $30.5K | Buy |
565
+276
| +96% | +$14.9K | ﹤0.01% | 935 |
|
|
2024
Q1 | $19.7K | Buy |
289
+20
| +7% | +$1.36K | ﹤0.01% | 890 |
|
|
2023
Q4 | $16.8K | Hold |
269
| – | – | ﹤0.01% | 895 |
|
|
2023
Q3 | $12.2K | Sell |
269
-30
| -10% | -$1.36K | ﹤0.01% | 943 |
|
|
2023
Q2 | $16.8K | Hold |
299
| – | – | ﹤0.01% | 789 |
|
|
2023
Q1 | $13.5K | Sell |
299
-15
| -5% | -$678 | ﹤0.01% | 837 |
|
|
2022
Q4 | $12.8K | Sell |
314
-100
| -24% | -$4.07K | ﹤0.01% | 790 |
|
|
2022
Q3 | $27K | Hold |
414
| – | – | ﹤0.01% | 562 |
|
|
2022
Q2 | $25K | Hold |
414
| – | – | ﹤0.01% | 501 |
|
|
2022
Q1 | $26K | Sell |
414
-8
| -2% | -$502 | ﹤0.01% | 484 |
|
|
2021
Q4 | $32K | Buy |
422
+151
| +56% | +$11.5K | 0.01% | 460 |
|
|
2021
Q3 | $30K | Buy |
271
+167
| +161% | +$18.5K | 0.01% | 379 |
|
|
2021
Q2 | $17K | Hold |
104
| – | – | ﹤0.01% | 463 |
|
|
2021
Q1 | $13K | Buy |
104
+15
| +17% | +$1.88K | ﹤0.01% | 486 |
|
|
2020
Q4 | $14K | Buy |
89
+60
| +207% | +$9.44K | ﹤0.01% | 433 |
|
|
2020
Q3 | $2K | Hold |
29
| – | – | ﹤0.01% | 587 |
|
|
2020
Q2 | $2K | Hold |
29
| – | – | ﹤0.01% | 547 |
|
|
2020
Q1 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 461 |
|